As of Jul 02
| -0.05 / -0.92%|
The 2 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +38.89% increase from the last price of 5.40.
The current consensus among 3 polled investment analysts is to Hold stock in Accretive Health Inc. This rating has held steady since June, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.